Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting de novo restorative regimens

被引:5
作者
Famta, Paras [1 ]
Shah, Saurabh [1 ]
Dey, Biswajit [2 ]
Kumar, Kondasingh Charan [1 ]
Bagasariya, Deepkumar [1 ]
Vambhurkar, Ganesh [1 ]
Pandey, Giriraj [1 ]
Sharma, Anamika [2 ]
Srinivasarao, Dadi A. [1 ]
Kumar, Rahul [2 ]
Guru, Santosh Kumar [2 ]
Raghuvanshi, Rajeev Singh [3 ]
Srivastava, Saurabh [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res NIPER, Dept Pharmaceut, Pharmaceut Innovat & Translat Res Lab PITRL, Hyderabad 500037, Telangana, India
[2] Natl Inst Pharmaceut Educ & Res NIPER, Dept Biol Sci, Hyderabad 500037, India
[3] Govt India, Cent Drugs Stand Control Org, New Delhi 110002, India
来源
CANCER PATHOGENESIS AND THERAPY | 2025年 / 3卷 / 01期
关键词
Breast cancer; Epithelial-to-mesenchymal transition; Metastases; Cancer stem cells; Epigenetics; STEM-CELLS; SUPPRESSOR-CELLS; MULTIDRUG-RESISTANCE; SIGNALING PATHWAY; PARP INHIBITORS; GENE-EXPRESSION; UP-REGULATION; EMT; PROMOTES; FIBROBLASTS;
D O I
10.1016/j.cpt.2024.01.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer (BC) is the most prevalent cancer in women globally. Anti-cancer advancements have enabled the killing of BC cells through various therapies; however, cancer relapse is still a major limitation and decreases patient survival and quality of life. Epithelial-to-mesenchymal transition (EMT) is responsible for tumor relapse in several cancers. This highly regulated event causes phenotypic, genetic, and epigenetic changes in the tumor microenvironment (TME). This review summarizes the recent advancements regarding EMT using dedifferentiation and partial EMT theories. We extensively review the mechanistic pathways, TME components, and various anti-cancer adjuvant and neo-adjuvant therapies responsible for triggering EMT in BC tumors. Information regarding essential clinical studies and trials is also discussed. Furthermore, we also highlight the recent strategies targeting various EMT pathways. This review provides a holistic picture of BC biology, molecular pathways, and recent advances in therapeutic strategies.
引用
收藏
页码:30 / 47
页数:18
相关论文
共 244 条
[1]   EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration [J].
Aiello, Nicole M. ;
Maddipati, Ravikanth ;
Norgard, Robert J. ;
Balli, David ;
Li, Jinyang ;
Yuan, Salina ;
Yamazoe, Taiji ;
Black, Taylor ;
Sahmoud, Amine ;
Furth, Emma E. ;
Bar-Sagi, Dafna ;
Stanger, Ben Z. .
DEVELOPMENTAL CELL, 2018, 45 (06) :681-+
[2]  
Al-Harbi Bothina, 2018, Oncotarget, V9, P17825, DOI 10.18632/oncotarget.24895
[3]   PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation [J].
Almozyan, Sheema ;
Colak, Dilek ;
Mansour, Fatmah ;
Alaiya, Ayodele ;
Al-Harazi, Olfat ;
Qattan, Amal ;
Al-Mohanna, Falah ;
Al-Alwan, Monther ;
Ghebeh, Hazem .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (07) :1402-1412
[4]   Osteoprotegerin (OPG) mediates the anti-carcinogenic effects of normal breast fibroblasts and targets cancer stem cells through inhibition of the β-catenin pathway [J].
Alraouji, Noura N. ;
Hendrayani, Siti-Fauziah ;
Ghebeh, Hazem ;
Al-Mohanna, Falah H. ;
Aboussekhra, Abdelilah .
CANCER LETTERS, 2021, 520 :374-384
[5]   Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells [J].
Alsuliman, Abdullah ;
Colak, Dilek ;
Al-Harazi, Olfat ;
Fitwi, Hanaa ;
Tulbah, Asma ;
Al-Tweigeri, Taher ;
Al-Alwan, Monther ;
Ghebeh, Hazem .
MOLECULAR CANCER, 2015, 14
[6]  
Alves-Guerra MC, 2011, Encycl Cancer, P2559, DOI [10.1007/978-3-642-16483-54132, DOI 10.1007/978-3-642-16483-54132]
[7]   PD-1/PD-L1 checkpoint in hematological malignancies [J].
Annibali, O. ;
Crescenzi, A. ;
Tomarchio, V. ;
Pagano, A. ;
Bianchi, A. ;
Grifoni, A. ;
Avvisati, G. .
LEUKEMIA RESEARCH, 2018, 67 :45-55
[8]   Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells [J].
Apostolou, Panagiotis ;
Toloudi, Maria ;
Ioannou, Eleni ;
Kourtidou, Eleni ;
Chatziioannou, Marina ;
Kopic, Asir ;
Komiotis, Dimitrios ;
Kiritsis, Christos ;
Manta, Stella ;
Papasotiriou, Ioannis .
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2013, 33 (06) :353-358
[9]   Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing [J].
Augustin, Yolanda ;
Staines, Henry M. ;
Krishna, Sanjeev .
PHARMACOLOGY & THERAPEUTICS, 2020, 216
[10]   Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and sternness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms [J].
Avtanski, Dimiter ;
Garcia, Anabel ;
Caraballo, Beatriz ;
Thangeswaran, Priyanthan ;
Marin, Sela ;
Bianco, Julianna ;
Lavi, Aaron ;
Poretsky, Leonid .
CYTOKINE, 2019, 120 :155-164